What we do

At Kenvue, we realize the extraordinary power of everyday care. Built on over a century of heritage and rooted in science, we’re the house of iconic brands - including NEUTROGENA®, AVEENO®, TYLENOL®, LISTERINE®, JOHNSON’S® and BAND-AID® that you already know and love. Science is our passion; care is our talent.

Who We Are

Our global team is ~ 22,000 brilliant people with a workplace culture where every voice matters, and every contribution is appreciated.  We are passionate about insights, innovation and committed to delivering the best products to our customers. With expertise and empathy, being a Kenvuer means having the power to impact millions of people every day. We put people first, care fiercely, earn trust with science and solve with courage – and have brilliant opportunities waiting for you! Join us in shaping our future–and yours. For more information, click here.

Role reports to:

Location:

Work Location:

What you will do

The R&D Analytical Senior Scientist is responsible for delivering analytical projects for the Self-Care portfolio (Drug Products), supporting Latin America at both local and regional levels.

This individual will independently lead the execution of analytical activities related to test method development and validation, will also write and review technical documents, including analytical method assessments, method validation/transfer protocols and reports, applied statistics, and GMP documentation. This individual will also be responsible for transferring test methods to the quality control laboratory and leading laboratory activities related to troubleshooting, laboratory investigations, and material characterization, as well as performing analyses and independently operating equipment such as HPLC/UPLC and GC-FID, among others.

Key Responsibilities

·        Lead the execution of stability studies, method development, validation, and method transfer to the quality control laboratory, and support related activities (test method creation/revision, change controls, investigation support, etc.);

·       Write and review technical documents including analytical method assessments, validation protocols and validation reports in accordance with standard operating procedures and regulatory requirements;

·       Conduct analyses for development and stability studies, including critical evaluation of results;

·       Represent the team in analytical and technical discussions;

·       Communicate clearly with the internal organization (Kenvue Self Care related areas – Regulatory, Product Development, Quality & Compliance, etc.);

·       Collaborate effectively with project members following priorities, checkpoints, and timelines to support milestones;

·       Communicate issues that require escalation;

·       Demonstrate a sense of urgency in actively responding to problems and opportunities.

What we are looking for

Required Qualifications

·       Bachelor’s degree in Pharmacy, Chemistry, Chemical Engineering, or related fields; postgraduate education in Analytical Development/Validation or Quality Assurance is a plus. (Aligned with ANVISA GMP requirements for qualified personnel);

·       Proficiency in HPLC/UPLC, GC, USP dissolution systems, data integrity systems and LIMS/ELN.

·       Validation and verification of analytical methods (HPLC/UPLC, GC, UV/Vis, IR) according to RDC 166/2017 (selectivity, linearity, range, accuracy, precision, LOD/LOQ, robustness, matrix effect, method transfer, and revalidation). Extensive expertise in method validation and method transfer execution;

·       Stability studies (accelerated, long‑term, and follow‑up) according to RDC 318/2019.

·       GMP compliance: Documentation, data integrity, CAPA, change control, audits.

·       Use of official compendia, especially the USP, Brazilian, and FEUM pharmacopoeias.

·       Ability to work independently and in a team environment;

·       Intermediate level of English (oral and written communication). 

Desired Qualifications

·       Development and validation of dissolution methods for oral solid dosage forms, according to the Dissolution Guide – ANVISA Guide nº 14/2021 v2 (medium selection, apparatus, agitation, temperature, discriminative power, and acceptance criteria).

·       Forced degradation studies and establishment of degradation profiles and mass balance, aligned with ICH Q1A(R2) and Brazilian requirements for degradation products.

·        Impurity control and risk assessment, including:

o    Elemental impurities per ICH Q3D(R2);

o    Degradation products under the national regulatory framework (RDC 964/2025 — RDC 821/2023 and IN 258/2023 and annex).

If you are an individual with a disability, please check our Disability Assistance page for information on how to request an accommodation.